Cancer Research UK logo.
SearchDonate
  • Search

A study of relatlimab and nivolumab for certain types of advanced cancer (CA224020)

Overview

Cancer types:

Melanoma, Secondary cancers

Status:

Closed

Phase:

Phase 1/2

Details

This study is looking at a new drug called relatlimab to see how well it works alongside nivolumab for certain types of advanced cancer. It is for people whose cancer has spread elsewhere in the body and/or it can’t be removed by surgery.

Recruitment start: 14 December 2016

Recruitment end: 30 July 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr James Larkin

Supported by

Bristol-Myers Squibb

Last reviewed: 25 May 2022

CRUK internal database number: 15385

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.